Buscar
Mostrando ítems 1-10 de 320
Pneumococcal Nasopharyngeal Carriage Among Infants Born to Human Immunodeficiency Virus-infected Mothers Immunized With Pneumococcal Polysaccharide Vaccine During Gestation
(LIPPINCOTT WILLIAMS & WILKINS, 2011)
Background: We have previously shown that 23-valent pneumococcal polysaccharide vaccine (PPV) is immunogenic in human immunodeficiency virus (HIV)-infected mothers and provides vaccine-induced antibodies to the infant. We ...
Effect of childhood pneumococcal vaccination and beta-lactam antibiotic use on the incidence of invasive pneumococcal disease in the adult population
Describe the incidence of invasive pneumococcal disease (IPD) in serotypes with reduced antibiotic sensitivity to penicillin (RAS-Pen) in adults over 59 years of age and its association with childhood anti-pneumococcal ...
Evaluation of antibody response to the heptavalent pneumococcal conjugate vaccine in pediatric chronic kidney disease
(SPRINGER, 2009)
Pneumococcal vaccination has been recommended for immunocompromised children, including patients with chronic kidney disease. We determined pneumococcal immunoglobulin (Ig) G antibodies to serotypes 4, 6B, 9V, 14, 18C, ...
Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children
(The Journal of Infection in Developing Countries, 2015-01-08)
Introduction: Pneumococcal pneumonia (PP) has a high burden of morbimortality in children. Use of pneumococcal conjugate vaccines (PCVs) is an effective preventive measure. After PCV 7-valent (PCV7) withdrawal, PCV 10-valent ...
23-valent pneumococcal vaccine. Statement of the consultive committee of immunizations on behalf of the Chilean Infectious Diseases Society: February 2010 Declaración del Comité Consultivo de Inmunizaciones de la Sociedad Chilena de Infectología acerca de
(Sociedad Chilena de Infectologia, 2010)
The article summarizes the scientific evidence related with protection conferred by the 23 valent polysacchardie vaccine against invasive pneumococcal disease, non bacteriemic pneumococcal pneumonia, and probable pneumococal ...
Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants
(ELSEVIER SCI LTD, 2009)
Whether gestational immunization of HIV-infected mothers with the 23-valent pneumococcal polysaccharide vaccine (PPV) confers maternal and infant early life, passive protection is not known. We evaluated safety, immunogenicity ...
Response to pneumococcal polysaccharide vaccine in children with asthma, and children with recurrent respiratory infections, and healthy children
(Elsevier, 2016)
Background: To analyse specific immune response to the 23-valent pneumococcal polysaccharide vaccine by measuring pneumococcal antibodies in children with asthma and with respiratory recurrent infection (RRI) as compared ...